Company: INKT
Filing Date: 2025-04-18
Form Type: PRE 14A
Source: 0000950170-25-055881
Chunk: 41

Company: MiNK Therapeutics, Inc.
Filing Date: 2025-04-18
Form: PRE 14A
Chunk 41
---
 they were granted, as of April 24, 2025. [Insert pie chart showing percentage of Eligible Options by year of grant.] The following table sets forth the number of Eligible Options held by our named executive officers, our other executive officers as a group, our non-executive directors, certain employees holding more than 5% of the total Eligible Options, our other employees as a group, and our other consultants as a group.

| Eligible Stock Options              |     |                           |     |                         |     |       |
| Name                                |     | Unvested Eligible Options |     | Vested Eligible Options |     | Total |
| Jennifer S. Buell, Ph.D.            |     |                           |     |                         |     |       |
| Marc van Dijk, Ph.D.                |     |                           |     |                         |     |       |
| Christine M. Klaskin                |     |                           |     |                         |     |       |
| Other executive officers as a group |     |                           |     |                         |     |       |
| Non-executive directors as a group  |     |                           |     |                         |     |       |
| [   ](1)                            |     |                           |     |                         |     |       |
| [   ](1)                            |     |                           |     |                         |     |       |
| [   ](1)                            |     |                           |     |                         |     |       |
| Other employees as a group          |     |                           |     |                         |     |       |
| Other consultants as a group        |     |                           |     |                         |     |       |
| TOTAL                               |     |                           |     |                         |     |       |

(1) Employees holding greater than 5% of the [ ] total Eligible Options.

<div align='center'>28</div>

Exchange Ratio

The Option Exchange is a one-for-one exchange. Thus, each Eligible Option will be replaced by a new option covering the same number of shares, but with a new exercise price and ten-year term. The overall number of stock options outstanding will remain the same. Each of the new stock options will have an exercise price equal to the closing price of a share of our common stock on the date on which it is granted, which is expected to be the date of the 2025 Annual Meeting.

Vesting Schedules for New Options

New stock option awards will be subject to the